Glen, C., Adam, S., Coats, C. J. and Lang, N. N. (2023) Reply: Cardiotoxicity of BRAF/MEK inhibitors according to HFA/ICOS cardiotoxicity risk category. JACC: CardioOncology, 5(6), p. 850. (doi: 10.1016/j.jaccao.2023.10.003) (PMID:38204997) (PMCID:PMC10774785)
Text
315227.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 78kB |
Abstract
No abstract available.
Item Type: | Articles (Letter) |
---|---|
Additional Information: | CG and NNL are supported by an unrestricted grant from Roche Diagnostics. NNL is supported by a British Heart Foundation Centre of Research Excellence grant (RE/18/6/34217). |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Coats, Dr Caroline and Lang, Professor Ninian and Adam, Sarah and Glen, Dr Claire |
Authors: | Glen, C., Adam, S., Coats, C. J., and Lang, N. N. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | JACC: CardioOncology |
Publisher: | Elsevier |
ISSN: | 2666-0873 |
ISSN (Online): | 2666-0873 |
Copyright Holders: | Copyright: © 2023 The Authors |
First Published: | First published in JACC: CardioOncology 5(6): 850 |
Publisher Policy: | Reproduced under a Creative Commons licence |
University Staff: Request a correction | Enlighten Editors: Update this record